QuidelOrtho (QDEL) Stock: Buy, Sell, or Hold?

QDEL - QuidelOrtho Corporation Common Stock

IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
$11.78
-0.37 (-3.05%) β–Ό
5d: -15.43%
30d: -20.57%
90d: -16.39%
WAIT
LOW Confidence
Protect Your QDEL Gains
Analysis Updated: Sep 11, 2026 12:00 AM ET
Earnings: Nov 04, 2026

Get Alerted When QDEL Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

πŸ’‘
Bottom Line:
⏸️ WAIT FOR STABILIZATION: QDEL is down 15.4% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
See Forward Earnings Fair Value & Price Prediction β†’

Long-Term Wealth Forecast (2031)

Based on Analyst Consensus Growth & Historical Valuation

0% (Stagnation) 50% (Hyper Growth)
EST. PRICE IN 2031
$21.62
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$13.43
12.3% Margin of Safety

How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 7.7x Exit PE.

In-depth Analysis How we analyze

Valuation Analysis: QDEL is currently trading at $11.78, which is considered oversold relative to its 30-day fair value range of $13.01 to $15.90. The stock's valuation (Forward PE: 8.2) is in line with its historical norms (7.7). At these levels, the market is pricing in 1.9% annual earnings growth.

Technical Outlook: Technically, QDEL is in a strong downtrend. The price is currently testing key support at $11.77. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 3.0% recently.

Market Sentiment: The stock scores a mixed 43/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $14.67 (+24.5%). Current signals suggest waiting for a better entry point before initiating new positions.

Quick Decision Summary

Current Position OVERSOLD
Historical Trading Range $13.01 - $15.90
Company Quality Score 46/100 (HOLD)
Volume Confirmation HIGH
Confidence Score 82.3%

Protect Your Profits

Holding QDEL? Use our AI-powered strategies to protect your downside while keeping your long-term position.

View Profit Protection Plan

All Signals

  • BULLISH: Price oversold vs 30-day range
  • BULLISH: Options cheap (IV 0th percentile)
  • NEUTRAL: Mixed technical signals (43/100)
  • BULLISH: High volume confirmation
  • BEARISH: Downward momentum (-3.0%)
  • BULLISH: Trading 24.5% below Wall St target ($14.67)
  • BULLISH: Expecting earnings turnaround to 1.9% growth with 2.8% revenue growth
  • WARNING: Composite score 46/100 in the bottom quintile β€” this cohort historically lags the market

Trading Range Analysis

30-Day Trading Range $13.01 - $15.90
Current vs Trading Range OVERSOLD
Expected Move (7 Days) Β±$1.27 (10.8%)

Support & Resistance Levels

Support Level $11.77
Resistance Level $15.11
Current Trend Strong Downtrend
Technical data as of Sep 11, 2026

Fundamental Context

Forward P/E (Next Year Est.) 8.17
Wall Street Target $14.67 (+24.5%)
Revenue Growth (YoY) 2.8%
Earnings Growth (YoY) -77.1%
Profit Margin -39.2%
Valuation Premium vs History +1.9% premium
PE vs Historical 8.2 vs 7.7 FAIR
Market-Implied Price Targets If current PE multiple persists
Implied Growth (YoY): +1.9% (market-implied from PE analysis)
1-Year Target $12.00 (+2%)
2-Year Target $12.23 (+4%)
3-Year Target $12.46 (+6%)
3-Yr Target (if PE normalizes) (PE: 8β†’8) PE COMPRESSION $11.75 (0%)
Earnings growth offset by PE compression
3-Year Scenarios Using analyst projected EPS growth
Bull: (PE: 20.2, Growth: 86.2%) $98.17 (+733%)
Base: (SPY PE: 8.2, Growth: 86.2%) $39.76 (+238%)
Bear: (PE: 6.9, Growth: 86.2%) $33.79 (+187%)
Share & Embed Analysis

Found this analysis useful? Share it with your community or embed the live chart on your blog.

Tweet Reddit
bloggers & journalists: you are free to use our charts with attribution.
Last updated: September 11, 2026 8:57 PM ET
Data refreshes hourly during market hours. Next update: 9:57 PM
πŸ”₯ Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL

Unlock Insider Activity

See real-time buying/selling by company executives for QDEL.

Create Free Account

Already have an account? Log In

Top Rated Medical Devices Stocks

Top-rated stocks in Medical Devices by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
BSX
Boston Scientific Corp
STRONG BUY
34 analysts
$63 49 HOLD
DXCM
DexCom Inc
STRONG BUY
27 analysts
$94 40 HOLD
SYK
Stryker Corporation
BUY
32 analysts
$383 44 HOLD
MDT
Medtronic PLC
BUY
32 analysts
$105 52 HOLD
PODD
Insulet Corporation
STRONG BUY
24 analysts
$172 41 HOLD

Advanced QDEL Option Strategies

Professional options setups generated by AI based on today's QDEL price and gamma walls.

Iron Condor Bull Call Bear Put Collar

More Analysis for QDEL

QDEL Technical Chart QDEL Price Prediction QDEL Earnings Date Why is QDEL Moving Today? QDEL Investment Advisor QDEL Fair Price Analyzer QDEL Options Advisor QDEL Options Chain QDEL Options Analysis QDEL Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals